Mergers and Aquisitions in the Global Pharmaceutical Industry: Implications for Pharmaceutical Business Strategies and Africa’s Health Agenda
−In-depth analysis of mergers and acquisitions in the global pharmaceutical industry
−Data-driven insights into the implications of M&A’s on cost of medicines, procurement strategies and Africa’s health agenda.
−Paper based on consolidation of data from E&K Consulting’s own work and data from pharmaceutical companies, GAVI, Global Fund and Malaria No More.
−Sponsored by E&K Consulting